Previous 10 | Next 10 |
Senate Democrats introduced a $21B emergency supplemental funding bill on Thursday to respond to the next phase of the pandemic, including the threat of new variants of the coronavirus. The measure unveiled by Senators Patrick Leahy (D-Vt.), Patty Murray (D-Wash.) and Christopher ...
Sanofi ( NASDAQ: SNY ) Q2 sales grew on the back of blockbuster drug Dupixent and Rare Disease business, while the company also raised its FY22 business EPS outlook. Q2 Business EPS rose +16.7% Y/Y (at Constant exchange rates, or CER) to €1.73, while sal...
Regeneron Genetics Center Discovers Rare Mutations In The CIDEB Gene That Protect Against Liver Disease PR Newswire New research published in The New England Journal of Medicine reveals that people with certain genetic loss-of-function mutations have more than 50% ...
Regeneron Announces the 2022 Winners of the Regeneron Prize for Creative Innovation PR Newswire TARRYTOWN, N.Y. , July 26, 2022 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the winners of the 10th annual Regener...
For further details see: Drug pricing legislation will affect biopharma revenue, but impact is manageable - RBC
A newly published study indicates that Evusheld, a monoclonal antibody therapy developed by AstraZeneca ( NASDAQ: AZN ) which is available in the U.S. for pre-exposure prophylaxis of COVID-19 might be less effective against new sub lineages of Omicron. The study was designed...
Although the healthcare sector has largely resisted this year's downward pressure, it is likely to succumb as pressure increases. Healthcare stocks have a well-deserved reputation for cyclical defense, but they are more likely to underperform in "secular" bear markets. Healthcare ...
A business that has high margins has much more of a buffer to handle adversity and rising costs. If a company's cost of revenue is significant and leaves little of the top line left to cover overhead and other operating expenses, it can be difficult to consistently stay in the black. A ...
Results from the APOLLO-B study are due any day now and will significantly impact sentiment around ALNY shares, as well as the revenue potential of Onpattro. A clearly successful outcome could quadruple revenue, but it's possible that the trial could meet its primary outcome and fail ...
Palm Beach, FL – July 18, 2022 – FinancialNewsMedia.com News Commentary – Particulate matter or particle pollution is a significant contributor to heart and lung disease. Individuals most affected by poor air quality have asthma, chronic obstructive pulmonary di...
News, Short Squeeze, Breakout and More Instantly...
Regeneron Pharmaceuticals Inc. Company Name:
REGN Stock Symbol:
NASDAQ Market:
Regeneron Pharmaceuticals Inc. Website:
A look at the top 10 most actives in the United States Qualigen Therapeutics Inc. (QLGN) rose 111.4% to $0.4341 on volume of 412,713,755 shares Maxeon Solar Technologies Ltd. (MAXN) fell 1.3% to $0.2375 on volume of 280,800,277 shares NVIDIA Corporation (NVDA) rose 1.4% to $129.24 on volu...
2024-07-12 11:00:05 ET Trung Huynh from UBS issued a price target of $1,250.00 for REGN on 2024-07-12 10:18:00. The adjusted price target was set to $1,250.00. At the time of the announcement, REGN was trading at $1092.3075. The overall price target consensus is at $902....
A look at the top 10 most actives in the United States Maxeon Solar Technologies Ltd. (MAXN) rose 3.6% to $0.2493 on volume of 118,503,418 shares Qualigen Therapeutics Inc. (QLGN) rose 94.8% to $0.4 on volume of 100,863,101 shares AgriFORCE Growing Systems Ltd. (AGRI) rose 20.0% to $0.098...